Description
A metabolite of PGD2 and an agonist of DP2; binds DP2 (Ki = 50 nM) and induces activation of eosinophils (EC50 = 8 nM); induces PPARγ-mediated transcription in a reporter assay at 5 µM; cytotoxic to L1210 murine leukemia cells (IC50 = 0.3 µg/ml); inhibits ADP-induced platelet aggregation (IC50 = 320 ng/ml) less potently than PGD2
Formal name: 9α-hydroxy-11-oxo-prosta-5Z,12E,14E-trien-1-oic acid
Synonyms: 15-deoxy-Δ12,14-PGD2
Molecular weight: 334.5
CAS: 85235-11-6
Purity: ≥95%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Lipids|Prostaglandins||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer|Cell Death||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway